GS-9450

DRUG3 trials

Sponsors

Gilead Sciences

Conditions

HCV InfectionNonalcoholic Steatohepatitis

Phase 2

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

CompletedNCT00725803

Gilead SciencesHCV Infection

Start: 2008-04-30End: 2009-03-31Updated: 2014-06-19

Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

CompletedNCT00740610

Gilead SciencesNonalcoholic Steatohepatitis

Start: 2008-08-31End: 2009-09-30Updated: 2014-02-04

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

TerminatedNCT00874796

Gilead SciencesHCV Infection

Start: 2009-05-31End: 2010-07-31Updated: 2014-02-04